Monday, December 9, 2013

Medical News

Medical News


Genetic counseling could help bipolar patients adapt

Posted: 09 Dec 2013 04:00 PM PST

Patients who believe their bipolar disorder is inherited tend to have a positive approach to coping with their condition, research suggests.

Pemetrexed, paclitaxel regimens equally effective in NSCLC

Posted: 09 Dec 2013 04:00 PM PST

PointBreak trial results suggest that pemetrexed- and paclitaxel-based chemotherapy offer comparable survival outcomes and tolerability for patients with advanced nonsquamous non-small-cell lung cancer (NSCLC) but with differing toxicity profiles.

Pemetrexed, paclitaxel regimens equally effective in NSCLC

Posted: 09 Dec 2013 04:00 PM PST

PointBreak trial results suggest that pemetrexed- and paclitaxel-based chemotherapy offer comparable survival outcomes and tolerability for patients with advanced nonsquamous non-small-cell lung cancer (NSCLC) but with differing toxicity profiles.

Genetic counseling could help bipolar patients adapt

Posted: 09 Dec 2013 04:00 PM PST

Patients who believe their bipolar disorder is inherited tend to have a positive approach to coping with their condition, research suggests.

Childhood trauma linked to poor social functioning in adult psychosis

Posted: 09 Dec 2013 04:00 PM PST

Adults with first-episode psychosis who report childhood trauma tend to have poorer social functioning than those without such a history, a prospective study has shown.

Supraglottic index, teaching program validated

Posted: 09 Dec 2013 04:00 PM PST

A scoring system known as the supraglottic index is valuable in assessing patients with asthma complicated by laryngopharyngeal reflux, researchers report.

Childhood trauma linked to poor social functioning in adult psychosis

Posted: 09 Dec 2013 04:00 PM PST

Adults with first-episode psychosis who report childhood trauma tend to have poorer social functioning than those without such a history, a prospective study has shown.

Novel multi-kinase inhibitor shows early promise in NSCLC

Posted: 08 Dec 2013 04:00 PM PST

Researchers have reported promising early data on an investigational drug that targets two tyrosine kinase receptors that drive invasive growth and drug resistance in non-small-cell lung cancer.

Novel multi-kinase inhibitor shows early promise in NSCLC

Posted: 08 Dec 2013 04:00 PM PST

Researchers have reported promising early data on an investigational drug that targets two tyrosine kinase receptors that drive invasive growth and drug resistance in non-small-cell lung cancer.

No comments:

Post a Comment